# Safety and Efficacy of Chlorthalidone + Amiloride to Elderly Patients Treatment With Arterial Hypertension

> **NCT01191450** · PHASE3 · COMPLETED · sponsor: **Eurofarma Laboratorios S.A.** · enrollment: 246 (actual)

## Conditions studied

- Arterial Hypertension

## Interventions

- **DRUG:** Chlorthalidone 25 mg + amiloride hydrochloride 5 mg
- **DRUG:** Higroton® Laboratório Novartis

## Key facts

- **NCT ID:** NCT01191450
- **Lead sponsor:** Eurofarma Laboratorios S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 246 (ACTUAL)
- **Last updated:** 2025-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01191450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01191450, "Safety and Efficacy of Chlorthalidone + Amiloride to Elderly Patients Treatment With Arterial Hypertension". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT01191450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*